Cyclopharm Ltd has released a press release.
Chairmans Address to Shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cyclopharm
- S&P DJI Announces March 2021 Quarterly Rebalance
- Confirmation of Technegas USFDA Timetable
- Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020
- Cyclopharm Successfully Completes A$30 Million Placement
- SNMMI Requests USFDA to Expedite Approval For Technegas
Later from Cyclopharm
- Managing Directors Address to Shareholders
- CYC First Half Trading Update
- Half Year 2021 Financial Results
- Cyclopharm USFDA Update
- S&P DJI Announces March 2022 Quarterly Rebalance
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm